[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Bayer A G Ord (BAYZF)

Bayer A G Ord (BAYZF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 20.57
  • Price/Book 5.23
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.1400 +4.49%
on 08/03/26
57.5700 -1.74%
on 08/05/26
+1.3300 (+2.41%)
since 07/31/26
3-Month
38.9400 +45.27%
on 06/02/26
61.3800 -7.84%
on 07/02/26
+15.0900 (+36.38%)
since 06/01/26
52-Week
30.0000 +88.57%
on 11/04/25
61.3800 -7.84%
on 07/02/26
+24.0237 (+73.81%)
since 08/25/25

Most Recent Stories

More News
Bayer Announces Phase III REVEAL Study with Investigational PET Radiotracer Iodine 124 Evuzamitide Presented as Late-Breaker at ESC 2026

Phase III results in patients with suspected cardiac amyloidosis were presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in The Journal of the American...

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Bayer to Present New Phase III Data from Its Cardiovascular, Kidney, and Stroke Clinical Trial Programs at ESC 2026

Presentations include investigational late-breaking KERENDIA ® (finerenone) data in chronic kidney disease (CKD), including a pooled analysis from studies in patients with and without diabetes...

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
LYNKUET® (elinzanetant) Receives Expanded Market Authorization in Canada for Treatment of Moderate to Severe Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy (AET) Related to Breast Cancer

Expanded authorization introduces a treatment option for women experiencing moderate to severe hot flashes and/or night sweats caused by adjuvant endocrine therapy (AET) related to breast cancer ...

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
One A Day® Introduces New Women's Multi Gummy Formula with 1,000 mcg Biotin

New Formula Delivers Daily Nutritional Support for Hair, Skin and Nails* Key Facts One A Day® Women's Multi Gummy vitamins...

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
New Economist Enterprise Research Highlights Why Integrating Self-Care Into Health Systems Matters

New research by Economist Enterprise, supported by Bayer, highlights the potential of self-care to become a more integrated component of modern health systems The research underscores...

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months Autonomy technology is designed to lower capital expenditures and...

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
The University of Colorado Anschutz, along with UCHealth and Children’s Hospital Colorado, Form Strategic Alliance with Bayer to Advance Drug Development and Clinical Trials

Bayer’s first academic medical center alliance for clinical trial collaboration is designed to accelerate medical discovery and expand patient access to investigational therapies

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Luke Bryan and One A Day® Launch Limited Edition Multivitamin Bottles Available Only at Walmart

One A Day®, the multivitamin and supplement brand from Bayer, has partnered with country superstar and five time Entertainer of the Year Luke Bryan to launch a limited edition multivitamin bottle featuring...

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)
Bayer Group to Consolidate U.S. Glyphosate Business Into Distinct Entity Operating as Ruveon

Advances key component of Crop Science division’s Five-Year Framework strategy Reinforces commitment to delivering trusted Roundup ® brands and glyphosate...

BAYRY : 14.2345 (+0.81%)
BAYZF : 56.5700 (+0.41%)
BAYN : 0.0100 (unch)

Business Summary

Bayer AG is an international research-based company active in life sciences, polymers, and chemicals. Bayer's operating units include health-care products, material sciences, and crop sciences. Bayer's over-the-counter health-care product division is the third-largest in the world. HealthCare subgroup...

See More

Key Turning Points

3rd Resistance Point 56.5700
2nd Resistance Point 56.5700
1st Resistance Point 56.5700
Last Price 56.5700
1st Support Level 56.5700
2nd Support Level 56.5700
3rd Support Level 56.5700

See More

52-Week High 61.3800
Last Price 56.5700
Fibonacci 61.8% 49.3928
Fibonacci 50% 45.6900
Fibonacci 38.2% 41.9872
52-Week Low 30.0000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.